Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -817.97%-405.66K | -736.98%-885.35K | -2,673.19%-613.49K | -1,898.29%-219.37K | 68.53%-8.3K | 4.57%-44.19K | 14.40%-105.78K | -351.75%-22.12K | 20.29%-10.98K | 1.49%-26.37K |
| Net income from continuing operations | -1,295.02%-426.39K | -1,905.29%-3.14M | -9,450.01%-2.77M | -1,367.75%-304.44K | -71.34%-34.71K | 64.75%-30.57K | -35.01%-156.77K | -49.39%-29.05K | -23.26%-20.74K | 15.69%-20.26K |
| Remuneration paid in stock | --18.81K | --356.5K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non cashItems | ---- | 3,908.51%2M | --2M | --6.55K | ---- | ---- | --50K | --0 | --0 | ---- |
| Change In working capital | 114.05%1.91K | -10,484.30%-102.49K | -2,898.96%-193.8K | 704.18%78.52K | 532.08%26.41K | -42.12%-13.63K | 113.23%987 | -52.40%6.92K | 219.50%9.76K | -122.94%-6.11K |
| -Change in receivables | -173.69%-4.77K | -209.29%-999 | -9.56%-1.23K | -4.53%3.73K | -84.34%-1.77K | 19.29%-1.74K | -110.04%-323 | -111.64%-1.12K | 713.97%3.91K | -14.05%-958 |
| -Change in prepaid assets | -4,452.17%-38.74K | ---8.07K | ---9.31K | --2.09K | ---1 | ---851 | --0 | --0 | --0 | --0 |
| -Change in payables and accrued expense | 511.62%45.42K | -7,231.45%-93.42K | -2,378.61%-183.27K | 1,142.12%72.7K | 646.65%28.18K | -48.49%-11.03K | 112.27%1.31K | 62.98%8.04K | 58.49%5.85K | -6.60%-5.16K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -817.97%-405.66K | -736.98%-885.35K | -2,673.19%-613.49K | -1,898.29%-219.37K | 68.53%-8.3K | 4.57%-44.19K | 14.40%-105.78K | -351.75%-22.12K | 20.29%-10.98K | 1.49%-26.37K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -184K | -270.57K | 86.58K | 0 | 0 | 0 | ||||
| Net business purchase and sale | ---- | --86.58K | --0 | --86.58K | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other investing changes | ---- | ---270.57K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---184K | ---270.57K | --86.58K | ---- | ---- | --0 | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.41M | 0 | 1.41M | 0 | 0 | 0 | ||||
| Net common stock issuance | ---- | --1.43M | --0 | --1.43M | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---27.42K | --0 | ---27.42K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | --1.41M | --0 | --1.41M | ---- | ---- | --0 | --0 | --0 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 139.68%578.68K | -30.46%241.44K | 454.98%1.46M | -31.18%188.95K | -34.45%197.25K | -30.46%241.44K | -26.25%347.22K | -25.15%263.56K | -24.97%274.54K | -23.37%300.91K |
| Current changes in cash | -817.97%-405.66K | 418.81%337.24K | -3,896.29%-884.06K | 11,703.09%1.27M | 68.53%-8.3K | 4.57%-44.19K | 14.40%-105.78K | -351.75%-22.12K | 20.29%-10.98K | 1.49%-26.37K |
| End cash Position | -12.28%173.02K | 139.68%578.68K | 139.68%578.68K | 454.98%1.46M | -31.18%188.95K | -34.45%197.25K | -30.46%241.44K | -30.46%241.44K | -25.15%263.56K | -24.97%274.54K |
| Free cash from | -817.97%-405.66K | -736.98%-885.35K | -2,673.19%-613.49K | -1,898.29%-219.37K | 68.53%-8.3K | 4.57%-44.19K | 14.40%-105.78K | -351.75%-22.12K | 20.29%-10.98K | 1.49%-26.37K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.